Which patents cover Talwin 50, and what substitute generic drugs are available?Talwin 50 is a drug marketed by Sanofi Aventis Us and is included in one NDA.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
Sanofi Aventis Us
|TABLET;ORAL||016732-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.